Cancer Supportive Care Products Market Research Reports Offers Key Insights
Jan 18, 2017
The market is likely to reach US$ 25.35 Bn in 2016. Erythropoietin stimulating agents will register the highest consumption. North America is expected to retain the largest market.
Valley Cottage, United States - January 18, 2017 /MarketersMedia/ —
Rising prevalence of cancers and adverse effects cases during cancer treatment will remain the most prominent factor driving the demand for cancer supportive care products on a global level. FMI indicates steady growth prospects for the global cancer supportive care products market over 2016-2021. The market is likely to reach US$ 25.35 Bn in 2016. Erythropoietin stimulating agents will register the highest consumption. North America is expected to retain the largest market.
Growing prominence of cancers is anticipated to spur the demand for supportive care. In addition, rising incidences of side-effects of anti-cancer therapy and superior results of existing anti-cancer drugs will collectively propel consumption of cancer supportive care products globally. Awareness about the usage of supportive care in cancer treatment, especially in developing countries, will also be a key factor highlighting the growing popularity of cancer supportive care products. Government initiatives regarding improved healthcare infrastructure, rising R&D investments, and augmenting healthcare spending are identified to be the major factors positively impacting the market growth. Since the past few years, innovative drug development has been on the priority for leading manufacturers. This is predicted to be a booster to the demand for cancer supportive care products.
Request For Report Sample with Table of Contents: http://www.futuremarketinsights.com/reports/sample/rep-gb-2550
However, high costs and inadequate reimbursement policies will remain longstanding challenges to the market growth. Moreover, promising entry of biosimilar drugs and loss of generic drugs brand exclusivity may also detain the market post-2016.
By drug class, the global cancer supportive care products market has eight key segments i.e. non-steroidal anti-inflammatory drugs, anti-infective, anti-emetics, monoclonal antibodies, erythropoietin stimulating agents, opioid analgesics, bisphosphonates, and granulocyte colony stimulating factors. Erythropoietin stimulating agents segment will continue to dominate with over 24% value share in 2016. Granulocyte colony stimulating factors will however be the second largest segment with almost 20% market share by 2016 end.
Based on disease indication, lung cancer will continue to dominate other segments, including melanoma, leukemia, breast cancer, liver cancer, prostate cancer, bladder cancer, ovarian cancer, and others. Breast cancer segment is likely to emerge at the highest growth rate. This growth is attributed to increasing cases of genetic inheritance, evolving lifestyle of women, and rising adoption of hormone replacement therapy.
Preview On Cancer Supportive Care Products Market Segmentation By Drug Class - Nonsteroidal Anti-Inflammatory Drugs, Anti-Infective, Anti-Emetics, Monoclonal Antibodies, Erythropoietin Stimulating Agents and Bisphosphonates; By Indication - Lung Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer and Ovarian Cancer; By Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Compounding Pharmacies: http://www.futuremarketinsights.com/reports/cancer-supportive-care-products-market
On the basis of distribution channel, the market is classified into three key segments viz. hospital pharmacies, retail pharmacies, and compounding pharmacies.
By geography, North America will remain the key market with over 43% market value share, followed by Europe with around 20% share by 2016, in terms of revenues. However, APAC is expected to witness at the fastest growth rate, creating the most lucrative market.
The key players participating in the global cancer supportive care products marketplace, include Baxter International Inc, Novartis Ag., Johnson & Johnson, Amgen Inc., Hoffmann LA- Roche Ltd, APR Applied Pharma Science Research S.A., Teva Pharmaceuticals Industries Ltd, Fagron Group BV, Acacia Pharma Ltd., and Kyowa Hakko Kirin Co Ltd. Leading manufacturers are increasingly concentrating on developing new supportive care products to stand out from competition.
Send An Enquiry: http://www.futuremarketinsights.com/askus/rep-gb-2550
Long-term Outlook: Over 2016-2021, the global market for cancer supportive care products is poised to expand at a CAGR of around 4.5%, reaching a value of US$ 29.87 Bn by 2021 end.
Contact Info:
Name: Abhishek Budholiya
Organization: Future Market Insights
Address: 616 Corporate Way, Suite 2-9018,, Valley Cottage, NY 10989,, United States
Phone: +13479183531
Source URL: http://marketersmedia.com/cancer-supportive-care-products-market-research-reports-offers-key-insights/162524
For more information, please visit http://www.futuremarketinsights.com/reports/cancer-supportive-care-products-market
Source: MarketersMedia
Release ID: 162524
More News
Use of GLP-1s Like Ozempic Is Forcing Food Companies to Adapt
People on medications for weight loss are buying less food, shrinking their portion sizes and purchasing smaller clothes. Businesses are trying to adjust.
Flight chaos caused by 'millisecond' software defect, report says
The failure led to more than 2,000 flights being cancelled and hundreds of thousands of passengers affected.
Kremlin Moves to Seize Control of Nestlé’s Russia Operations
The Swiss maker of KitKats and Nescafé said it was assessing the situation after the Kremlin issued a presidential decree.
Amodei, Anthropic’s Leader, Exposed A.I.’s Dangers. It’s Time to Act.
Times columnist Kevin Roose sees reasons for optimism — and worry — as the world wakes up to what Silicon Valley has been talking about for years.
Dragon Deborah opens with a terrible negotiation tactic
Deborah Meaden makes a bold opening move in response to a pitch.
'Insufficient funds' to pay Brewdog creditors after takeover deal
Administrators say about £489,000 was owed for staff wages and holiday pay and £2.4m was owed to HMRC for unpaid VAT.
China Stockpiled Oil, and Now It Could Dominate the Energy Landscape
The war with Iran revealed just how much influence the world’s biggest oil importer has over prices and other countries’ supplies of jet fuel, gasoline and diesel.
British Steel plan lacks credibility, MPs say
A committee report says the government has not set out how British Steel will become profitable.
Native American Tribe Teams Up With Kalshi on New Prediction Market
The Tunica-Biloxi of Louisiana plan to release a platform that uses infrastructure by Kalshi, the industry leader. Other tribes have taken aim at the company.
Economy minister accuses SoS of 'mischief making' in social media exchange
Dr Caoimhe Archibald posted on X about a new one-off electricity bill reduction, which Sir Chris Bryant reposted saying the UK government funded it.
We bought our £242,000 home without a deposit - here's how
The share of UK mortgages with smaller deposits is the highest it's been since 2008. The BBC spoke to borrowers about how they manage the risks.
Former shoplifter ran 'steal-to-order' Whatsapp group
Keeley Knowles ran a Whatsapp group with about 200 people asking her to steal specific designer items.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.